| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Caspase-3|CASP-3|Apopain|Cysteine protease CPP32|Protein Yama|SREBP cleavage activity 1|SCA-1|CASP3|CPP32 |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
human CASP3 (Caspase-3) is a molecular target commonly studied in cancer, metabolism, and neuroscience research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.
Biological role and mechanism
The biological role of CASP3 is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of CASP3 can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
CASP3 (Caspase-3) may also be referenced as Caspase-3, CASP-3, and Apopain in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how CASP3 relates to tumor microenvironment biology, cell proliferation and apoptosis, metastasis and invasion pathways, and angiogenesis and immune-oncology mechanisms in cancer, metabolism, and neuroscience research.
- Interpreting shifts in CASP3 levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
CASP3 has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with cancer, metabolism, and neuroscience studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Curcumin, thymoquinone, and 3, 3′-diindolylmethane combinations attenuate lung and liver cancers progression
IF: 5.988 Journal: Frontiers in Pharmacology Cited Date: 2022-07-07
Programmed cell death markers in COVID-19 survivors with and without sepsis
IF: 5.7 Journal: Frontiers in Immunology Author: Department of Transplant Immunology and Stem Cell Lab, Global Medical Education and Research Foundation, Hyderabad, India Cited Date: 2025-02-28
Novel Venetin-1 nanoparticle from earthworm coelomic fluid as a promising agent for the treatment of non-small cell lung cancer
IF: 4.996 Journal: Scientific Reports Cited Date: 2022-11-10
Balancing between apoptosis and survival biomarkers in the patients with tuberculous meningitis
IF: 3.926 Journal: Cytokine Cited Date: 2022-07-14
Attenuation effect of polydeoxyribonucleotide on inflammatory cytokines and apoptotic factors induced by particulate matter (PM10) damage in human bronchial cells
IF: 3.606 Journal: Journal of Biochemical and Molecular Toxicology Cited Date: 2020-10-16
Curcumin and Thymoquinone Combination Attenuates Breast Cancer Cell Lines' Progression
IF: 3.279 Journal: Integrative Cancer Therapies Cited Date: 2022-05-26
Distinct cell death markers identified in critical care patient survivors diagnosed with sepsis
IF: 3.276 Journal: Immunology Letters Cited Date: 2021-05-06
An ellagitannin-loaded CS-PEG decorated PLGA nano-prototype promotes cell cycle arrest in colorectal cancer cells
IF: 2.989 Journal: Cell Biochemistry and Biophysics Cited Date: 2023-04-21